Haemoprotection against cytostatic drugs by stem cell inhibition
- 31 December 1991
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 12 (8) , 304-310
- https://doi.org/10.1016/0165-6147(91)90582-d
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Protection from arabinofuranosylcytosine and n-mustard-induced myelotoxicity using hemoregulatory peptide pGlu-Glu-Asp-Cys-Lys monomer and dimerBlood, 1991
- Developmental potential of hematopoietic stem cells determined using retrovirally marked allophenic marrowBlood, 1991
- The use of haemoregulatory peptides (pEEDCK monomer and dimer) for reduction of cytostatic drug induced haemopoietic damageCancer Treatment Reviews, 1990
- High dose cytosine arabinoside in the initial treatment of adults with acute lymphoblastic leukaemiaBritish Journal of Cancer, 1990
- The sequence of the hemoregulatory peptide is present in Giα proteinsFEBS Letters, 1990
- Effects of transplantation on the primitive immunohematopoietic stem cell.The Journal of Experimental Medicine, 1990
- The biology and clinical potential of growth factors that regulate myeloid cell productionTrends in Pharmacological Sciences, 1990
- Leukemia Following Chemotherapy for Ovarian CancerNew England Journal of Medicine, 1990
- Selectivity of hemoregulatory peptide (HP5b) action in cultureThe International Journal of Cell Cloning, 1990
- Isolation and Synthesis of a Hemoregulatory PeptideZeitschrift für Naturforschung C, 1982